KYTHERA Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market. KYTHERA's longer-term strategy is to leverage its biotechnology and aesthetics experience to expand its product portfolio and pipeline. KYTHERA has submitted regulatory filings for ATX-101 (known as KYBELLA™ in the U.S. and BELKYRA™ in Canada) in Switzerland and Australia.
View Top Employees from Kythera Biopharmaceuticals Inc| Website | http://www.kythera.com |
| Revenue | $21 million |
| Funding | $137.8 million |
| Employees | 24 (0 on RocketReach) |
| Founded | 2005 |
| Address | 27200 W Agoura Rd, Ste 200, Calabasas, California 91301, US |
| Phone | (818) 587-4500 |
| Technologies | |
| Industry | Pharmaceuticals, Healthcare, Drug Manufacturing & Research, Biotechnology |
| Competitors | Ablynx, Kura Oncology, Inc., MyoKardia, Otonomy, Inc, Relypsa |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies |
Looking for a particular Kythera Biopharmaceuticals Inc employee's phone or email?
Kythera Biopharmaceuticals Inc Questions
The Kythera Biopharmaceuticals Inc annual revenue was $21 million in 2023.
Kythera Biopharmaceuticals Inc is based in Calabasas, California.
The NAICS codes for Kythera Biopharmaceuticals Inc are [3254, 32, 325, 32541].
The SIC codes for Kythera Biopharmaceuticals Inc are [283, 28].
Related Companies
